Skip to main content
padlock icon - secure page this page is secure

Carotenoids and Modulation of Cancer: Molecular Targets

Buy Article:

$68.00 + tax (Refund Policy)

Epidemiological studies have suggested an association between an increased dietary intake of carotenoids and a reduced incidence of cancer, even if results from clinical trials indicated that β-carotene supplements do not protect against cancer and might actually increase the risk of lung cancer in smokers. Although several mechanisms by which carotenoids modulate cancer process have been reported, there are still conflicting opinions and little is known regarding their mechanisms of action at molecular levels. It appears that carotenoids can bring about a host of changes at the levels of both gene expression and protein activity in the cells. In particular, some evidences are shown that carotenoid molecules may interfere in cancer related molecular pathways and change the expression of many proteins involved in: 1) cell proliferation, differentiation, apoptosis and angiogenesis; 2) carcinogen detoxification; 3) DNA damage and repair; 4) immunosurveillance. Carotenoids seem to affect gene expression either directly by interference with the control apparatus of the gene expression machinery or by virtue of metabolites or metabolic conditions induced (hormonal status, cellular redox status, etc.) that, in turn, alter cell functions implicated in the cancer process. The suppression as well as the induction of cancer by carotenoids raises issues about possible doses of carotenoid administration, possible synergy as well as antagonistic interactions between carotenoids and other dietary components.

Understanding the effects of carotenoids on cancer-related genetic pathways is fundamental, not only providing pathophysiological explanation for the development of cancer, but also improving strategies for cancer prevention.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Epidemiological; apoptosis; carcinogen; carotenoids; immunosurveillance

Document Type: Review Article

Affiliations: Institute of General Pathology, Catholic University, L.go F. Vito, 1, 00168 Rome, Italy

Publication date: March 1, 2004

More about this publication?
  • Current Pharmacogenomics provides comprehensive overviews of all current research on pharmacogenomics and pharmacogenetics. All areas of the field from pre-clinical to clinical research are covered, including related areas such as genomics, proteomics, target discovery, bioinformatics and novel diagnostics. This international journal is peer-reviewed and publishes both mini- and full review articles.

    The journal has become essential reading for all researchers and clinicians with interests in pharmacogenomics and pharmacogenetics.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more